WAAS

Viome, Inc.

Trademark Registered: 2022-11-01
Trademark Application Details
Trademark Logo WAAS
814
Live/Pending
SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Research OneLook Acronym Finder
Serial Number87984051
Registration Number6889843
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameAdam D. Matherly
Attorney Docket Number45964.002.02
Law Office AssignedL30
Employee NameIN, SUNG HYUN

Timeline

2016-11-11Application Filed
2017-03-28Published for Opposition
2020-12-26Date of First Use
2021-07-27Status: Live/Pending
2022-01-04Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
2022-01-04Transaction Date
2022-11-01Trademark Registered

Trademark Applicants & Owners

Owner: VIOME, INC.
Address205 108th Ave NE, Suite 150 Bellevue DE 98004
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Adam D. Matherly
KARR TUTTLE CAMPBELL
SUITE 3300
701 FIFTH AVENUE
SEATTLE, WA 98104

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:35
U.S. Codes:100,101,102
Type CodeType
GS0051Beverages containing probiotics for use as a nutritional supplement; beverages containing prebiotics for use as a nutritional supplement; dietary supplement drink mixes; dietary supplemental drinks; dietary supplements; dietary supplement drink mixes; food supplements; health food supplements; herbal supplements; medicines for the treatment of gastrointestinal diseases; mineral supplements; nutritional supplement energy bars; nutritional supplement shakes; nutritional supplements; nutritional supplements, namely, probiotic compositions; nutritional and dietary supplements formed and packaged as bars; nutritional supplements, namely, probiotic compositions; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; powdered nutritional supplement concentrate; powdered nutritional supplement drink mix; prebiotic supplements; probiotic supplements; protein supplements; vitamin supplements
GS0351Marketing services; subscription-based order fulfillment services in the field of health and wellness; advertising, marketing and promotion services; on-line advertising and marketing services

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2016-11-151 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2016-11-172 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2017-02-173 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER2017-02-184 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2017-03-085 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2017-03-286 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2017-03-287 NPUB E:E-Mail
EXTENSION OF TIME TO OPPOSE RECEIVED2017-04-208 ETOF T:TTAB Proceeding
OPPOSITION INSTITUTED NO. 9999992017-07-269 OP.I T:TTAB Proceeding
OPPOSITION DISMISSED NO. 9999992017-11-1610 OP.D T:TTAB Proceeding
OPPOSITION TERMINATED NO. 9999992017-11-1611 OP.T T:TTAB Proceeding
TTAB RELEASE CASE TO TRADEMARKS2017-11-1612 TMBN T:TTAB Proceeding
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2017-12-2613 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2018-06-2614 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2018-07-0215 AITU A:Allowance for Publication
EXTENSION 1 FILED2018-06-2616 EXT1 S:
EXTENSION 1 GRANTED2018-07-0217 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-07-0318 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2018-12-2619 EEXT I:Incoming Correspondence
EXTENSION 2 FILED2018-12-2620 EXT2 S:
EXTENSION 2 GRANTED2018-12-2621 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-12-2822 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2019-06-2623 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2019-06-2624 EXT3 S:
EXTENSION 3 GRANTED2019-06-2625 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-06-2826 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2019-12-2327 EEXT I:Incoming Correspondence
EXTENSION 4 FILED2019-12-2328 EXT4 S:
EXTENSION 4 GRANTED2019-12-2329 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-12-2530 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2020-06-2631 EEXT I:Incoming Correspondence
EXTENSION 5 FILED2020-06-2632 EXT5 S:
EXTENSION 5 GRANTED2020-06-2933 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-06-3034 EXRA E:E-Mail
TEAS STATEMENT OF USE RECEIVED2020-12-2835 EISU I:Incoming Correspondence
USE AMENDMENT FILED2020-12-2836 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2021-01-0537 SUPC I:Incoming Correspondence
SU - NON-FINAL ACTION - WRITTEN2021-01-2638 CNRT W:
NON-FINAL ACTION E-MAILED2021-01-2639 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2021-01-2640 GNRN O:Outgoing Correspondence
TEAS REQUEST TO DIVIDE RECEIVED2021-07-2641 ERTD I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2021-07-2642 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-07-2643 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2021-07-2744 TEME I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2022-01-0445 AITU A:Allowance for Publication
DIVISIONAL REQUEST RECEIVED2021-07-2646 DRRR I:Incoming Correspondence
DIVISIONAL PROCESSING COMPLETE2022-01-0447 DPCC D:Assigned to Examiner
SU - FINAL REFUSAL - WRITTEN2022-02-0848 CNFR W:
FINAL REFUSAL E-MAILED2022-02-0849 GNFR O:Outgoing Correspondence
NOTIFICATION OF FINAL REFUSAL EMAILED2022-02-0850 GNFN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2022-08-2251 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND2022-08-2252 MAB2 E:E-Mail
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED2022-09-0153 RGIA O:Outgoing Correspondence
NOTICE OF REINSTATEMENT E-MAILED2022-09-0254 MREI E:E-Mail
SU-EXAMINER'S AMENDMENT WRITTEN2022-09-2155 SNEA W:
EXAMINERS AMENDMENT E-MAILED2022-09-2156 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2022-09-2157 GNEN O:Outgoing Correspondence
ASSIGNED TO LIE2022-09-2158 ALIE A:Allowance for Publication
EXAMINER'S AMENDMENT ENTERED2022-09-2159 XAEC I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2022-09-2760 CNPR P:
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2022-09-2861 SUNA E:E-Mail
REGISTERED-PRINCIPAL REGISTER2022-11-0162 R.PR A:Allowance for Publication
NOTICE OF REGISTRATION CONFIRMATION EMAILED2022-11-0163 NRCC E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed